FDAnews Device Daily Bulletin

MILLIMED AND BLUE MEDICAL REFOCUS THEIR DRUG-ELUTING DEVICE OPERATIONS AS SEPARATE STAND ALONE ENTITIES

Nov. 21, 2005
A A

Bob Mitchell, CEO of Millimed and Ronald Horvers, CEO of Blue Medical recently announced that they have finalized a strategy that will realign their core businesses and will operate as stand alone entities. All commercial activities related to coronary stent and balloon development and production, as well as sales and marketing functions will continue as a separate entity under the name Blue Medical, headquartered in Helmond, The Netherlands.

Yahoo News (http://biz.yahoo.com/prnews/051118/laf012.html?.v=37)